• About us
  • Research
  • Pipeline
  • Investment
  • News
Menu
  • About us
  • Research
  • Pipeline
  • Investment
  • News
  • EN
  • ES
Menu
  • EN
  • ES
Contact
  • About us
  • Investment
  • Pipeline
  • Research
  • News
  • Contact
  • EN
  • ES
Menu
  • About us
  • Investment
  • Pipeline
  • Research
  • News
  • Contact
  • EN
  • ES

About us

  • Tetraneuron
  • Our history
  • Tetraneuron
  • Our history

Leading the charge against neurodegenerative diseases through groundbreaking gene therapy innovation

  • About us
    Our dedication to research and commitment to neurological health place us at the forefront of science and medicine, with a clear mission: to improve the lives of those facing these devastating conditions.

    At Tetraneuron, we believe in a future where neurodegenerative diseases no longer signify relentless suffering and decline. Instead, we envision personalized and effective therapies that bring hope and enhance quality of life. This dream is what drives us to work tirelessly every day.
  • Our mission
    Our mission is to revolutionize the landscape of neurodegenerative diseases by providing safe and effective gene therapies targeting disorders like Alzheimer's and other aging-related neurodegenerative conditions. We're dedicated to scientific excellence and ethical standards at every stage of our journey.
  • Our Experience
    At Tetraneuron, our team consists of scientists and biotechnology experts who have dedicated their careers to researching and developing gene therapies for neurodegenerative diseases. With our expertise in neuroscience and technology, we approach complex medical challenges in innovative ways.

Our history

2023

New strategic alliances in Parkinson and aging

2022

Pre-IND meeting with the FDA

2021

Beginning of the preclinical regulatory phase

2020

Methode validation of TET-101

2019

Analysis of biological processes modulated by E2F4DN

2018

Validation of the Leading Compound

2017

Validation of the Leading Compound

2016

Identification of the Leading Compound

2015

Validation of the therapeutical target E2F4DN

2014

Beginning of the proof of concept

2013

Identification of the therapeutical target E2F4

2012

Tetraneuron was founded

Tetraneuron es una empresa biotecnológica española de terapia génica centrada en las enfermedades cerebrales y neurodegenerativas

Con sede en Madrid y Valencia, Tetraneuron nace como spin-off del Instituto Cajal, perteneciente al Consejo Superior de Investigaciones Científicas (CSIC)

Comprometidos con la excelencia científica y la ética en cada paso del camino.

Our team

Team
Strategic Advisors
Team
Strategic Advisors
Loading...
José M. Frade. PhD

Scientific Director and co-Founder

Álvaro Pascual-Leone. MD.PhD

Scientific Board Member

Teodoro del Ser. MD. PhD

Scientific Board Member

David Mor

Board Member

Mari Carmen Álvarez. PhD

Managing Director

Mar Municio. PhD

R&D Director

Noelia López Sánchez. PhD

Technical Director

Cristina Sánchez Puelles. PhD

Senior Researcher

Morgan Ramón Landrau

Researcher

Alberto Garrido

Laboratory Technician

Vanesa Cano

Laboratory Technician

Irene Camacho

PhD. Student

Loading...
Marika Russo. PhD

Strategic Advisor

Alonso Fernández Nistal, PhD

Strategic Advisor

Ángel Lucio Pereira

Strategic Advisor

Collaborating Institutions

csic-1
instituto_cajal
incliva-logo
hospital-universitario-la-princesa
amsterdan-umc
funcacion-cien

Would you like to know more about Tetraneuron?

We invite you to join this new path for neurodegenerative diseases

CONTACT

A new path for neurodegenerative diseases

Contact

VALENCIA
BIOHUB VLC
Travesía s/n 15 E Base 5,
46024 Valencia

MADRID
C/ Velázquez, 154 – Pta Baja Izda A , 28002 Madrid

Ⓒ 2023 Tetraneuron S.L. All Rights Reserved

  • Cookies policy
  • Legal disclaimer
  • Cookies policy
  • Legal disclaimer
Cookie Notice
The website of TETRANEURON S.L. uses its own and third-party cookies for functional purposes (allow web browsing), to optimize browsing and personalize it according to your preferences as well as to show you advertising based on your browsing profile (e.g. pages visited). Click HERE for more information. You can accept all cookies by pressing the “ACCEPT” button or reject their use by pressing the “DECLINE” button.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}

Contact

Online contact form

TETRANEURON S.L processes your personal data in order to be able to manage the queries you ask us. You can exercise your rights of access, rectification, deletion, opposition, portability and limitation through our email info@tetraneuron.com. For more information you can access our Privacy Policy

VALENCIA
BIOHUB VLC
Travesía s/n 15 E Base 5,
46024 Valencia

MADRID
C/ Velázquez, 154 – Pta Baja Izda A , 28002 Madrid